Catalyst Research Grant


This award is intended to stimulate the entry of early-career scientists into areas of research related to eczema, as they seek to become an independent research investigator with a commitment to this field.

Catalyst Research Grants provide promising early investigators with seed grants to help establish a novel and promising line of eczema research, and gather a preliminary, yet meaningful body of data to carry this area of study forward. Data from Catalyst awards can then be used to seek additional, larger-scale funding from the National Institutes of Health (NIH) or other funding entities to conduct additional investigations.

Proposals should address at least one of the following research priorities:

  • Cutting Edge Basic & Translational Science*
  • Eczema Heterogeneity: Novel Insights
  • Innovations in Clinical Practice & Care
  • Understanding & Alleviating Disease Burden
  • Eczema Prevention

Number of Awards

This is a 1-year non-renewable grant, with an expected start date of January 1, 2025. Awards are contingent on the receipt of sufficiently meritorious applications. Additional awards may be available at NEA discretion.


Assistant Professors (or equivalent) without current or previous NIH R funding as a Senior or Co-PI, Post-doctoral fellows, Medical Residents or Fellows, Research Associates, and Nurse Practitioners are eligible to apply.

Previous recipients of NEA research grants still meeting these eligibility criteria may apply.

The applicant must be personally and actively responsible for the conduct of the proposed research. The applicant need not be a United States citizen and the research need not take place in the United States.


Applicants may request up to $50,000 (USD; direct costs only). Indirect costs are not allowed on NEA research awards.

Salary/fringe benefit support for Assistant Professors (or equivalent) should be commensurate with the percent effort dedicated to the project, using the current allowable NIH salary cap.

For all other applicants, a maximal 50% effort with associated salary/fringe is allowable for the PI role. Additional research staff support should also be commensurate with project percent effort.

How To Apply

Review and download the NEA Catalyst Research Grant Application. See the NEA grant conditions of award and frequently asked questions for additional award information and requirements.

The following steps will need to be taken in order to successfully submit your NEA research grant application for review:

  1.  Fill out the research grant application in its entirety.
  2.  Make sure your document is merged with all relevant documentation.
  3.  Submit your NEA Research Grant Application via our APPLICATION PORTAL. Please fill out all the required fields in our online research grant intake form.   
  4.  The application portal is where you can upload your application and any supporting documentation to NEA.
  5.  You will be given an email confirmation when we receive your application.  If you do not receive an email confirmation, please check your Junk folder.

Completed applications must be received by Wednesday, July 31, 2024 at 5 p.m. PDT. NO EXCEPTIONS can be made to this deadline.

Award notifications are anticipated after November 30, 2024.

Email with any additional questions on this award or the award process.

NEA Research Banner
NEA is the largest private nonprofit funder of research for adult and pediatric eczema, investing more than $4 million to date. We are dedicated to increasing the number of scientists, research projects and research dollars devoted to eczema, in pursuit of better therapies, better care, better outcomes –– and one day, potentially, a cure.
Applying Organization Details

If US based, use two letter abbreviation.

Principal Investigator Details

If US based, use two letter abbreviation.

Institutional Representative Details

If your grant application is approved, the institutional representative will receive the grant agreement for electronic signature first.

Grant Details

Get the latest eczema news delivered to your inbox.